Mazor Robotics: Strong Sell as Orders Register a Decline

On Apr 14, Zacks Investment Research downgraded Mazor Robotics Ltd MZOR to a Zacks Rank #5 (Strong Sell).

Why the Downgrade?

The downgrade primarily reflects lower orders for the Renaissance system in the first quarter of 2016. The company received 5 orders as compared to a record 12 in the fourth quarter of 2015.

In the first quarter, Mazor installed 4 systems in the U.S., including one with brain module, which is primarily used to assist Deep Brain Stimulation (DBS) procedures to treat movement disorders. The company has also installed six systems with the brain module in the U.S.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button